Medicare Enrolled
Dr. Andrew Hesseltine, MD
Pain Medicine · Colton, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hesseltine from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hesseltine?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hesseltine
Dr. Andrew Hesseltine is a pain medicine specialist in Colton, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Hesseltine performed 1,957 Medicare services across 941 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hesseltine received a total of $46,292 from 75 pharmaceutical and/or device companies across 833 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hesseltine is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 26% volume in CA
$46,292 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,957
Medicare services
Top 26% in CA for pain medicine
941
Unique beneficiaries
$82
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~98 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,390 | $82 | $630 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
218 | $48 | $137 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
66 | $131 | $1,036 |
| Spinal drug pump reprogramming and refill Electronic adjustment of the settings for a spinal drug infusion pump and replenishment of the medication reservoir. |
48 | $73 | $686 |
| Spinal drug pump reprogramming and refill A physician electronically adjusts the settings of a spinal drug infusion pump and refills its medication reservoir. |
38 | $74 | $692 |
| Spinal or brain drug pump maintenance A healthcare professional performs maintenance on a drug infusion pump implanted in the spinal canal or brain. |
31 | $82 | $502 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
30 | $42 | $386 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
23 | $157 | $950 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
21 | $57 | $432 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
20 | $204 | $1,396 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
16 | $87 | $1,931 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
15 | $145 | $1,097 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
14 | $92 | $606 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
14 | $201 | $3,413 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
13 | $62 | $1,898 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$46,292
Total received (2018-2024)
Avg $6,613/year across 7 years
Top 7% in CA for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
75
Companies
833
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$23,430 (50.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$15,253 (32.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$7,610 (16.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,445
2023
$2,073
2022
$1,781
2021
$3,842
2020
$8,161
2019
$7,626
2018
$19,364
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,344
Nevro Corp.
$692
Medtronic, Inc.
$610
ABBVIE INC.
$204
Abbott Laboratories
$106
Electronic Waveform Lab, Inc.
$86
Valinor Pharma, LLC
$79
Vertos Medical, Inc.
$54
PFIZER INC.
$47
Averitas Pharma Inc.
$38
PAINTEQ LLC
$38
Collegium Pharmaceutical, Inc.
$31
SI-BONE, INC.
$29
VERTEX PHARMACEUTICALS INCORPORATED
$28
Virtus Pharmaceuticals LLC
$25
Curonix LLC
$18
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 76.8% of 2024 payments
All-time payments by company (2018-2024) ›
Nevro Corp.
$25,424
Takeda Pharmaceuticals U.S.A., Inc.
$4,869
Medtronic USA, Inc.
$3,113
Abbott Laboratories
$1,941
Boston Scientific Corporation
$1,584
Medtronic, Inc.
$1,534
PFIZER INC.
$552
Electronic Waveform Lab, Inc.
$501
ABBVIE INC.
$501
PAINTEQ LLC
$439
Vertiflex, Inc.
$387
Supernus Pharmaceuticals, Inc.
$372
Daiichi Sankyo Inc.
$370
Allergan, Inc.
$302
Lilly USA, LLC
$271
Merz Pharmaceuticals, LLC
$267
Zyla Life Sciences, Inc.
$198
Biohaven Pharmaceuticals, Inc.
$196
BioDelivery Sciences International, Inc.
$182
Horizon Therapeutics plc
$163
Collegium Pharmaceutical, Inc.
$161
SPR Therapeutics, Inc
$145
Scilex Pharmaceuticals Inc.
$142
BOSTON SCIENTIFIC CORPORATION
$139
Amgen Inc.
$124
Almatica Pharma LLC
$123
Allergan Inc.
$122
Lundbeck LLC
$118
Teva Pharmaceuticals USA, Inc.
$117
SI-BONE, Inc.
$87
Eisai Inc.
$87
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$84
Valinor Pharma, LLC
$79
Merck Sharp & Dohme LLC
$79
Stimwave Technologies Incorporated
$74
Kaleo, Inc.
$74
Averitas Pharma Inc.
$71
Stryker Corporation
$65
SCILEX PHARMACEUTICALS INC.
$65
Jazz Pharmaceuticals Inc.
$62
Novartis Pharmaceuticals Corporation
$59
AbbVie Inc.
$58
Vertos Medical, Inc.
$54
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$53
Shionogi Inc
$50
SI-BONE, INC.
$50
Pernix Therapeutics Holdings, Inc.
$48
FIDIA PHARMA USA INC.
$47
Purdue Pharma L.P.
$43
Assertio Therapeutics, Inc.
$42
ARBOR PHARMACEUTICALS, INC.
$42
ASSERTIO THERAPEUTICS, Inc.
$41
Arbor Pharmaceuticals, Inc.
$40
Curonix LLC
$39
Spinal Simplicity, LLC
$38
Biohaven Pharmaceutical Holding Company Ltd.
$37
VERTEX PHARMACEUTICALS INCORPORATED
$28
MEDLINE INDUSTRIES LP
$26
Egalet US Inc
$26
Virtus Pharmaceuticals LLC
$25
Alkermes, Inc.
$25
IDORSIA PHARMACEUTICALS US INC
$24
Azurity Pharmaceuticals, Inc.
$23
Neuronetics, Inc.
$22
Bioventus LLC
$20
TerSera Therapeutics LLC
$18
Merz North America, Inc.
$18
DePuy Synthes Sales Inc.
$18
Forte Bio-Pharma LLC
$18
Xeris Pharmaceuticals, Inc.
$16
INSYS Therapeutics Inc
$14
ERMI Inc.
$13
Relievant Medsystems, Inc.
$12
Baudax Bio Inc.
$11
AstraZeneca Pharmaceuticals LP
$11
Top 3 companies account for 72.2% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · AIMOVIG · AJOVY · ANJESO · Aimovig · Amitiza · Axium INS DRG IPG · BELBUCA · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BUNAVAIL · BUNAVAIL 2.1 mg 30-count box · Belbuca · CHANTIX · COLOGUARD · Cambia · DRG IPGs · Dayvigo · Durolane · EMGALITY · EVZIO · Evzio · FLECTOR · GENERAL PAIN MANAGEMENT · GRALISE · Gralise · HA MINUTEMAN G3-R · Horizant · Hymovis · IFUSE IMPLANT · INC. · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - IVAS · IVS - VERTEBRAL AUGMENTATION PRODUCTS · Intracept · KEVEYIS · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · LEVORPHANOL TARTRATE · LYRICA · MEDLINE INDUSTRIES · MOVANTIK · Morphabond ER · N'VISION · NALOCET · NEUROSTAR TMS THERAPY · NORTHERA · NURTEC ODT · NVISION · OCTRODE · ORTHOVISC · OXTELLAR XR · Omnia · PAINTEQ · PAXLOVID · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · QUTENZA · QUVIVIQ · RELISTOR · REYVOW · SPECTRA WAVEWRITER · SPRINT PNS System · SPRIX · SUBSYS · SUPERION · SYMPROIC · SYNCHROMED · Senza · Senza II · Senza Spinal Cord Stimulation System · StimQ Receiver Stimulator Kit Channel A US w Receiver · Superion · Superion ISS · Superion Indirect Decompression System · Symproic · TROKENDI XR · Trintellix · UBRELVY · VANTA ADAPTIVESTIM · VIVITROL · VYEPTI · Vanta · WaveWriter Alpha Prime 16 · XEOMIN · XTAMPZA · Xeomin · Xtampza ER · ZIPSOR · ZOHYDRO ER · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (51%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pain medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 7% for pain medicine in CA.
Geographic Context
Pain medicines within 10 mi
15
Per 100K population
0.7
County median income
$82,184
Nearest hospital
ARROWHEAD REGIONAL MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Hesseltine is a clinical cardiology specialist, with above-average Medicare volume (top 26% in CA), with speaking/promotional industry engagement in the top 7% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Hesseltine experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Hesseltine performed 1,390 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hesseltine receive payments from pharmaceutical companies?
Yes. Dr. Hesseltine received a total of $46,292 from 75 companies across 833 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hesseltine's costs compare to other pain medicines in Colton?
Dr. Hesseltine's average Medicare payment per service is $82. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hesseltine) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Colton
Browse pain medicines in Colton ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in CA
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in CA
Which CA pain medicines receive the most from drug and device companies.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology